[Survival in patients with malignant melanoma of the uvea].
In the study is given the analysis of the data of patients with malignant uveal melanoma from the tumor register of the Dpt. of Ophthalmology of the Med. Faculty, Comenius University, Bratislava, Slovak republic, in years 1988-1993. In this period there are registered 94 patients with malignant uveal melanoma, 0,86% of all treated patients. There are registered 22 cases (8,2%) in iris, in corpus ciliare 13 (13,8%), in chorioidea - 72 (76,6%). In this 6-years period 74 cases (78,8) were treated by radical surgical techniques (enucleation, block-excision), in 18 cases (19,6%) brachytherapy by episcleral beta-applicator (Ru106/Rh106) was used and 2 of the patients (2,1%) refused any kind of therapy. Follow-up 3 months to 6 years: life expectancy-we didn't mention significant difference in the mortality-rate in the group of 72 patients treated by radical surgical techniques and those (18 cases), who were treated by episcleral applicator (Kruskall-Wallis test). The mortality rate was 25% in group A (enucleation) and 33% in group B (beta-irradiation).